A patient sits across from me holding a lab report with every value printed in black, not red. No flags. No asterisks. "Everything's normal," the report says. And yet this same patient hasn't slept well in months, can't get through the afternoon without a crash, and feels like a shadow of the person they used to be.
This is one of the most common conversations I have at Alpha Care. And it points to something patients deserve to understand clearly: a "normal" lab result is not the same thing as an optimal one. In range is not always optimal.
What a Reference Range Actually Is
When your doctor's office reports that your vitamin D, magnesium, or B12 level is "within normal limits," that range describes a population, not you. A reference interval is built by measuring a group of reference individuals and keeping the middle 95% of their results, trimming 2.5% off each end. Which means that by construction, about one in twenty perfectly healthy people lands outside it. The range was drawn to describe who is typical. It was never drawn to define who is thriving.
This is not a fringe reading. The IFCC's own committee on reference intervals — the international body that sets standards for clinical laboratories — draws a firm line between a reference interval, which describes how results are distributed across a healthy population, and a clinical decision limit, which is tied to actual risk. It notes the two are routinely confused, and that a result falling outside a reference interval does not by itself indicate disease. Laboratory medicine has even named the territory in between: functional reference limits, the physiological targets that sit between "statistically typical" and "clinically diseased." That territory is where this work happens.
That distinction matters enormously. A laboratory reference interval describes where a result falls compared with a reference population; it does not, by itself, define the best target for every individual. Being in range does not automatically mean that every system is functioning optimally, and being outside a range does not automatically mean that a person is sick. Clinical meaning comes from the full picture: symptoms, history, examination, related markers, medications, genetics, nutrition, lifestyle, and change over time.
A Few Examples That Make This Concrete
Vitamin D makes the difference concrete. Some laboratory reports use a broad 25-hydroxyvitamin D interval of approximately 30–100 ng/mL, but that printed interval is not an instruction to push every patient toward the upper end. There is no single, universally established endpoint that is optimal for every person or every outcome. In selected patients, a clinician may use a narrower working target such as 40–60 ng/mL, informed by the clinical picture, observational research, experience, response to treatment, and the need to avoid excess. Even that is an example, not a universal prescription: the NIH Office of Dietary Supplements notes that potential adverse effects may occur above approximately 50 ng/mL and recommends avoiding sustained levels around 50–60 ng/mL or higher without a clear clinical reason and appropriate supervision.
Vitamin B12 illustrates the same principle from another direction. A laboratory may print a range of roughly 250–1,100 pg/mL, yet serum B12 alone can miss clinically meaningful insufficiency. Labcorp identifies 200–400 pg/mL as an equivocal zone in which methylmalonic acid may help clarify functional status, and neurologic, psychiatric, or hematologic findings can occur without a dramatic serum abnormality. In appropriate patients, we may work toward levels above 700 pg/mL, with some reporting their best function closer to 1,000 pg/mL, while also considering symptoms, blood counts, methylmalonic acid, homocysteine, absorption, medications, and the form of B12 used. Those are individualized clinical targets, not a promise that a particular number will produce a particular result.
Iron tells the story even better, and it is the one we see mislead people most often. Ferritin is the usual stand-in for iron stores, but it is also an acute-phase reactant, which means inflammation drives it up regardless of how much iron you actually have. So a patient can be genuinely iron-depleted and still post a ferritin that looks reassuring, or run a high ferritin that reflects inflammation rather than abundance. Reading ferritin next to serum iron and total iron-binding capacity, instead of on its own, is what keeps that from slipping past. It is a good illustration of the wider point: a number is only as good as the context you read it in.
Zinc, magnesium, selenium, iron, and other nutrients follow the same general pattern. An individualized target may need to be higher or lower than a population reference point depending on the person's biochemistry and clinical goals. The useful takeaway is not that higher is always better. It is that the gap between “not clearly deficient” and “functioning well” can be clinically meaningful, and the right target must be selected and monitored rather than assumed.
Why This Gap Exists
The RDA/AI system was built for population-level public health, and it does that job well. It is not designed to answer an individual clinical question: is this specific person's biochemistry optimized for energy production, hormone synthesis, and disease resistance? That is a fundamentally different question, and it requires a fundamentally different kind of range — one grounded in physiology, laboratory nuance, and how a person actually feels and functions.
This is also why two people can have the same laboratory number and completely different experiences. Two men can receive the same testosterone dose and reach similar testosterone and estradiol levels while one feels excellent and the other continues to feel average or poor. The number matters, but it does not describe receptor signaling, downstream metabolites, thyroid and adrenal function, nutrient cofactors, inflammation, insulin sensitivity, sleep, stress, recovery, genetics, or the many other variables shaping the response. That is biochemical individuality, and it is why a single marker should never be interpreted in a vacuum.
Reading Labs Like a Systems Biologist
At Alpha Care, the panel is never the whole picture — the person reading it with me is. I don't look at any single marker in isolation. The body is an interconnected system — a change in magnesium status doesn't just affect muscle cramps, it affects vitamin D activation, insulin signaling, and cardiovascular tone all at once. Reading labs through a functional medicine lens means asking what a value means in the context of every other system it touches, not just whether it clears an arbitrary cutoff.
That's why functional assessment often uses different, more sensitive markers than a standard panel: homocysteine read alongside B12 and folate rather than B12 alone, iron studies in full instead of a lone ferritin, and fasting insulin next to glucose rather than glucose by itself. None of this is guesswork — it reflects how these nutrients are studied and used in clinical nutrition, endocrinology, and metabolic cardiology when the goal shifts from prevention to true optimization.
Monitoring Is the Point, Not a One-Time Test
Optimal is also not static. A functional or therapeutic target is part of a feedback loop, not a finish line. That means repeating appropriate laboratory testing after a protocol begins, comparing the results with symptoms and clinical response, and adjusting the plan accordingly. Supraphysiologic or high-dose supplementation requires particularly careful monitoring. Too much or too little of almost anything in the body can create problems, and fat-soluble vitamins and minerals deserve special attention because accumulation, toxicity, imbalance, and nutrient-to-nutrient interactions are real concerns.
Over-the-counter does not mean risk-free. Blindly taking high doses because a product is available without a prescription can be harmful, especially when the plan involves fat-soluble vitamins, minerals, interacting supplements, kidney or liver disease, pregnancy, or prescription medications. Your laboratory goals, dosing range, formulation, and monitoring schedule should be determined from your individual presentation, biochemistry, and clinical assessment.
If you've been told your labs are normal but you don't feel normal, that isn't in your head, and it isn't something to just accept. It's a signal to ask a better question of your labs than the standard reference range was ever designed to answer.
